Evidence map›Paper›PMID 37337233›Full record

ArticleBMC medicine2023

Trajectories of cardiac troponin in the decades before cardiovascular death: a longitudinal cohort study.

Dorien M Kimenai, Atul Anand, Marie de Bakker, Martin Shipley, Takeshi Fujisawa, Magnus N Lyngbakken, Kristian Hveem, Torbjørn Omland, Carlos A Valencia-Hernández, Joni V Lindbohm and 8 more

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Data Resource Profile: The HUNT Biobank.International journal of epidemiology · 2024
    Article
  5. Article
  6. Cardiovascular biomarkers: exploring troponin and BNP applications in conditions related to carbon monoxide exposure.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 5 countries.

Dorien M Kimenai *British Heart Foundation/University Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, EH16 4SA, UK.
Atul Anand *British Heart Foundation/University Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, EH16 4SA, UK.
Marie de BakkerDepartment of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Martin ShipleyDepartment of Epidemiology and Public Health, University College London, London, UK.
Takeshi FujisawaBritish Heart Foundation/University Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, EH16 4SA, UK.
Magnus N LyngbakkenDepartment of Cardiology, Akershus University Hospital, Lørenskog, Norway.
Kristian HveemDepartment of Public Health and General Practice, HUNT Research Centre, Norwegian University of Science and Technology, Levanger, Norway.
Torbjørn OmlandDepartment of Cardiology, Akershus University Hospital, Lørenskog, Norway.
Carlos A Valencia-HernándezDepartment of Epidemiology and Public Health, University College London, London, UK.
Joni V LindbohmDepartment of Epidemiology and Public Health, University College London, London, UK.
Mika KivimakiDepartment of Epidemiology and Public Health, University College London, London, UK.
Archana Singh-ManouxDepartment of Epidemiology and Public Health, University College London, London, UK.
Fiona E StrachanUsher Institute, University of Edinburgh, Edinburgh, UK.
Anoop S V ShahDepartment of Non-Communicable Disease, London School of Hygiene and Tropical Medicine, London, UK.
Isabella KardysDepartment of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Eric BoersmaDepartment of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Eric J BrunnerDepartment of Epidemiology and Public Health, University College London, London, UK.
Nicholas L MillsBritish Heart Foundation/University Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, EH16 4SA, UK. nick.mills@ed.ac.uk.ORCID 0000-0003-0533-7991
British Heart Foundation · GBUniversity College London · GBErasmus MC · NLUniversity of Oslo · NOInserm · FRLondon School of Hygiene & Tropical Medicine · GBNorwegian University of Science and Technology · NOUniversity of Edinburgh · GBUniversity of Helsinki · FI

Funding

Education, socioeconomic status and Aging: transitions from multimorbidity to functional limitations and mortalityR01AG056477 · NIA · UNIVERSITY COLLEGE LONDON · PI KIVIMAKI, MIKA J, SINGH-MANOUX, ARCHANA · 2018 to 2022
$2.8M
Role of mid- and late-life risk factors in social inequalities in Alzheimer's Disease and Related DementiasRF1AG062553 · NIA · INSERM PARIS 5 · PI KIVIMAKI, MIKA J, SINGH-MANOUX, ARCHANA · 2019 to 2019
$1.5M
British Heart Foundation CH/F/21/90010British Heart Foundation FS/19/17/34172British Heart Foundation RE/18/5/34216British Heart Foundation RG/16/11/32334British Heart Foundation RG/20/10/34966Chief Scientist OfficeDepartment of HealthMedical Research Council MR/R024227/1Medical Research Council MR/S011676/1NIA NIH HHS R01 AG056477NIA NIH HHS RF1 AG062553
6 · The paper itself

Abstract

backgroundHigh-sensitivity cardiac troponin testing is a promising tool for cardiovascular risk prediction, but whether serial testing can dynamically predict risk is uncertain. We evaluated the trajectory of cardiac troponin I in the years prior to a cardiovascular event in the general population, and determine whether serial measurements could track risk within individuals.

methodsIn the Whitehall II cohort, high-sensitivity cardiac troponin I concentrations were measured on three occasions over a 15-year period. Time trajectories of troponin were constructed in those who died from cardiovascular disease compared to those who survived or died from other causes during follow up and these were externally validated in the HUNT Study. A joint model that adjusts for cardiovascular risk factors was used to estimate risk of cardiovascular death using serial troponin measurements.

resultsIn 7,293 individuals (mean 58 ± 7 years, 29.4% women) cardiovascular and non-cardiovascular death occurred in 281 (3.9%) and 914 (12.5%) individuals (median follow-up 21.4 years), respectively. Troponin concentrations increased in those dying from cardiovascular disease with a steeper trajectory compared to those surviving or dying from other causes in Whitehall and HUNT (P

conclusionsCardiac troponin I concentrations increased in those dying from cardiovascular disease compared to those surviving or dying from other causes over the preceding decades. Serial cardiac troponin testing in the general population has potential to track future cardiovascular risk.

Indexed as

Cardiovascular DiseasesBiomarkersCohort StudiesFemaleHumansLongitudinal StudiesMaleRisk FactorsTroponin IBiomarkersTroponin ICardiac troponinGeneral populationOutcomeRisk factors

Identifiers

PMID37337233
PMCPMC10280894
OpenAlexW4381250000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.